SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment.

Magavern, EF; Hitchings, A; Bollington, L; Wilson, K; Hepburn, D; Westacott, RJ; Sam, AH; Caulfield, MJ; Maxwell, S (2024) UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment. Br J Clin Pharmacol, 90 (2). pp. 493-503. ISSN 1365-2125 https://doi.org/10.1111/bcp.15919
SGUL Authors: Hitchings, Andrew William

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview
[img] Microsoft Word (.docx) (Appendix S1) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (168kB)
[img]
Preview
PDF (Data S1) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (6MB) | Preview

Abstract

AIMS: The United Kingdom (UK) Prescribing Safety Assessment (PSA) is a 2-h online assessment of basic competence to prescribe and supervise the use of medicines. It has been undertaken by students and doctors in UK medical and foundation schools for the past decade. This study describes the academic characteristics and performance of the assessment; longitudinal performance of candidates and schools; stakeholder feedback; and surrogate markers of prescribing safety in UK healthcare practice. METHODS: We reviewed the performance data generated by over 70 000 medical students and 3700 foundation doctors who have participated in the PSA since its inception in 2013. These data were supplemented by Likert scale and free text feedback from candidates and a variety of stakeholder groups. Further data on medication incidents, collected by national reporting systems and the regulatory body, are reported, with permission. RESULTS: We demonstrate the feasibility, high quality and reliability of an online prescribing assessment, uniquely providing a measure of prescribing competence against a national standard. Over 90% of candidates pass the PSA on their first attempt, while a minority are identified for further training and assessment. The pass rate shows some variation between different institutions and between undergraduate and foundation cohorts. Most responders to a national survey agreed that the PSA is a useful instrument for assessing prescribing competence, and an independent review has recommended adding the PSA to the Medical Licensing Assessment. Surrogate markers suggest there has been improvement in prescribing safety in practice, temporally associated with the introduction of the PSA but other factors could be influential too. CONCLUSIONS: The PSA is a practical and cost-effective way of delivering a reliable national assessment of prescribing competence that has educational impact and is supported by the majority of stakeholders. There is a need to develop national systems to identify and report prescribing errors and the harm they cause, enabling the impact of educational interventions to be measured.

Item Type: Article
Additional Information: © 2023 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: assessment, doctor, error, medication safety, medicine, pharmacist, prescribing, assessment, doctor, error, medication safety, medicine, pharmacist, prescribing, 1115 Pharmacology and Pharmaceutical Sciences, Pharmacology & Pharmacy
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Br J Clin Pharmacol
ISSN: 1365-2125
Language: eng
Dates:
DateEvent
30 January 2024Published
9 November 2023Published Online
15 September 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 37793701
Web of Science ID: WOS:001097469500001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116006
Publisher's version: https://doi.org/10.1111/bcp.15919

Actions (login required)

Edit Item Edit Item